Steven E. Hall's most recent trade in Kymera Therapeutics Inc was a trade of 20,063 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 16, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Steven E. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,063 | 20,063 | - | - | Stock Option (Right to Buy) |